Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...

Making the world smarter, happier, and richer.

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

But the bill also would prohibit mRNA vaccines, like those developed by Pfizer and Moderna to combat COVID-19, Shippy told the Idaho Statesman. Vaccines that use mRNA technology are not gene ...

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to target and destroy cancer cells. However, detailed scientific data ...

Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...

Reporting in Nature, Swingle et al. use a DNA barcoding approach to identify an LNP formulation that delivers therapeutic mRNA to the placenta and alleviates hypertension in mouse models of pre ...

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...

After hours: January 31 at 7:59:52 p.m. EST ...

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.